Addex Therapeutics raises USD 2.8 million via ATM equity distribution agreement
ADXN•ATM equity distribution agreement raises $2.8 million
Addex Therapeutics raised gross proceeds of USD 2.8 million through its at-the-market offering agreement with H.C. Wainwright.
- Sold 437,869 ADSs representing 52,544,280 shares under the equity distribution program.
- Cash runway extended to the fourth quarter of 2027 following the sales.
- Outstanding shares excluding treasury shares rose to 210,292,217; issued shares stayed at 218,654,496.
